Diagnostic DYADERM Fluorescence Diagnosis

Biocam Diagnostic DYADERM Fluorescence Diagnosis, for early detection of malignancies by fluorescence imaging, supporting the physician for the diagnosis of malignant melanoma as well as basal cell carcinoma, actinic keratosis, squamous cell disease, Morbus Bowen and other inflammatory diseases of the skin. 

The product, sold in the EU, does not seem to be FDA cleared.





Key features include:

• Real-time display of fluorescence and clinical in special overlay mode. 
• Usability under ambient light. Up to 3 live images (full screen, split screen).
• Fluorescence- guided biopsy and diagnosis (investigator-independent). 
• Detection of clinical invisible (incipient) lesions. 
• Monitoring of therapeutic success, e.g. following surgery, cryotherapy, PDT. Professional data base for documentation. Flexible arm for easy positioning of camera and light source. 
• Image spot size: typical 10 cm x 10 cm Filming speed: 33 Hz

Price: ~ $50,000